Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon T Jennings
Carrie McAdam Marx

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of the American Pharmacists Association : Japha|September 14, 2013
Team-based approach to addressing simvastatin safety concernsMcKay Robinson, Karen Gunning, Karly Pippitt, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain|June 21, 2017
Outcomes Associated with Pharmacist-Led Diabetes Collaborative Drug Therapy Management in a Medicaid PopulationEman Biltaji, Minkyoung Yoo, Brandon T Jennings, et al.
The American Journal of Managed Care|August 31, 2018
Economic implications with newer agents to reduce cardiovascular risk in diabetesCarrie McAdam-Marx
The American Journal of Managed Care|August 25, 2022
Addressing healthcare disparities and managed care considerations with continuous glucose monitoringCarrie McAdam-Marx
The American Journal of Managed Care|July 13, 2013
Economic implications of type 2 diabetes managementCarrie McAdam Marx
Journal of Managed Care & Specialty Pharmacy|February 25, 2023
Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United StatesXiaotong Zhang, Carrie McAdam Marx
The American Journal of Managed Care|November 13, 2008
Cost-effectiveness of insulin analogsDiana I Brixner, Carrie McAdam-Marx
Clinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analogJason R Young, Carrie McAdam-Marx
Expert Review of Cardiovascular Therapy|May 23, 2015
Once-weekly exenatide as a treatment for Type 2 diabetesMarisa B Schauerhamer, Holly Gurgle, Carrie McAdam-Marx
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United StatesJiayu Cui, Donald G Klepser, Carrie McAdam-Marx
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of the American Pharmacists Association : Japha|September 14, 2013
Team-based approach to addressing simvastatin safety concernsMcKay Robinson, Karen Gunning, Karly Pippitt, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain|June 21, 2017
Outcomes Associated with Pharmacist-Led Diabetes Collaborative Drug Therapy Management in a Medicaid PopulationEman Biltaji, Minkyoung Yoo, Brandon T Jennings, et al.
The American Journal of Managed Care|August 31, 2018
Economic implications with newer agents to reduce cardiovascular risk in diabetesCarrie McAdam-Marx
The American Journal of Managed Care|August 25, 2022
Addressing healthcare disparities and managed care considerations with continuous glucose monitoringCarrie McAdam-Marx
The American Journal of Managed Care|July 13, 2013
Economic implications of type 2 diabetes managementCarrie McAdam Marx
Journal of Managed Care & Specialty Pharmacy|February 25, 2023
Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United StatesXiaotong Zhang, Carrie McAdam Marx
The American Journal of Managed Care|November 13, 2008
Cost-effectiveness of insulin analogsDiana I Brixner, Carrie McAdam-Marx
Clinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analogJason R Young, Carrie McAdam-Marx
Expert Review of Cardiovascular Therapy|May 23, 2015
Once-weekly exenatide as a treatment for Type 2 diabetesMarisa B Schauerhamer, Holly Gurgle, Carrie McAdam-Marx
Journal of Managed Care & Specialty Pharmacy|June 29, 2021
Short-term cost-effectiveness of oral semaglutide for the treatment of type 2 diabetes mellitus in the United StatesJiayu Cui, Donald G Klepser, Carrie McAdam-Marx
Pageof 8